Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better ...
As of the end of the second quarter, the company had $7.5 billion remaining under its share repurchase authorization. On August 26, 2024, the Board of Directors approved an additional $50.0 billion in ...
Berkshire Hathaway leverages insurance float, amplifying returns up to 1.7x and serving as a low-cost capital source. Read ...
Corteva (CTVA) announced that its board of directors authorized a new $3B share repurchase program. The authorization is immediately effective, ...
ST. LOUIS, MISSOURI, US — The board of directors of Bunge Global SA have authorized the repurchase of an additional $500 ...
Boise Cascade's share repurchase program and dividend payments reflect confidence in its finances. See what supports a hold ...